Aldine Invests in AmPharm and New Age Medical
June 24, 2021
AmPharm
Aldine is pleased to announce an investment in AmPharm. AmPharm is an institutional Long Term Care pharmacy that provides a full suite of pharmaceutical offerings, including specialized packaging and IV services. The company serves senior living, skilled nursing, and rehabilitation centers; psychiatric hospitals; as well as home health and hospice locations, contributing to a diverse and synergistic offering across the post-acute continuum of care.
Aldine provided a subordinated note investment alongside Mitchell Family Office.
New Age Medical
Aldine is pleased to announce an investment in New Age Medical (“NAM”). NAM is a leading value-added distributor of spinal implants and orthopedic products to hospitals, health systems and ambulatory surgical centers in the Midwest and Southeast. NAM occupies a niche as an intermediary between hospitals and medium- and small-sized OEMs. As vendor of record with hospitals, hospital systems and ambulatory surgery centers, NAM grants its OEMs coveted access to key accounts, while granting surgeons access to a diverse portfolio of products that includes cutting edge technology.
Aldine provided a subordinated note and equity investment alongside Compass Group Equity Partners.
Aldine Capital Partners
Aldine Capital Partners is a private investment firm which provides junior capital financing to lower middle-market companies. Aldine invests $4-25 million per transaction in a combination of subordinated debt and equity. Collaborating with traditional and independent sponsors as well as talented management teams, Aldine deploys capital to facilitate growth, support acquisitions/buyouts, or provide shareholder liquidity. Our success is built on a collaborative approach that harnesses over 100 years of combined experience and relationships to create tailored capital solutions